Hyperalgesia Clinical Trial
Official title:
Opioid Induced Hyperalgesia (OIH) Modulation With Propranolol, in Laparoscopic Abdominal Surgery
Opioid Induced Hyperalgesia (OIH) is an entity than has been demonstrated in healthy
volunteers and in animal models. Is defined as an increase in the perception to painful
stimuli, increasing the opioid requirements and diminishing the pain thresholds to stimuli.
The apparition of OIH is also related to the exposure to opioids during surgery, depending
of the dose, the time of exposition and the type of opioid.
This condition can be modulated, specially in the perioperative context. It has been seen in
healthy volunteers and in animal models, than the use of propranolol can modulate this
phenomena, diminishing the postoperative requirements of analgesia. It is also unknown, the
dose of propranolol required to modulate adequately OIH.
The objective of this work is to evaluate the efficacy of propranolol in the modulation of
opioid induced hyperalgesia, with lower postoperative requirements of analgesia rescue.
This is a randomized controlled study, comparing 2 interventions with a placebo. The
interventions will be use of propranolol, at different doses, to achieve specific plasmatic
concentrations.
80 patients will be required to find a difference of 20% in the primary outcome.
The primary outcome to be measured is the postoperative use of opioids in the post
anesthesic care unit.
Secondary outcomes, will be the amount of opioids used in the following 24 hours to the
surgery, the time to the first dose of analgesia in the post anesthesic care unit, and the
change in the pain thresholds, evaluated as pain by pressure and by tactile sensitivity,
before and after surgery.
Also, as a secondary outcome, in a group than will not receive the study drug, we will
evaluate the temporal changes in opioid induced hyperalgesia, by pain sensitivity measured
in the postoperative hours 2, 4 and 24. 10 patients receiving placebo will be part of this
additional measures.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01301079 -
Evaluation of the Effect of Ketamine on Remifentanil-induced Hyperalgesia
|
Phase 3 | |
Completed |
NCT00833755 -
Effect of Ketamine on Opioid-Induced Hyperalgesia
|
N/A | |
Completed |
NCT00279032 -
GW406381 In Patients With Peripheral Nerve Injury
|
Phase 1 | |
Completed |
NCT03793790 -
The Role of Learning in Nocebo Hyperalgesia
|
N/A | |
Completed |
NCT03985995 -
Pain Response to Cannabidiol in Induced Acute Nociceptive Pain, Allodynia and Hyperalgesia By Using a Model Mimicking Acute Pain in Healthy Adults
|
N/A | |
Completed |
NCT04199858 -
Electrophysiological Correlates of Nocebo Effects on Pain
|
N/A | |
Completed |
NCT02938455 -
DNA Methylation and Perioperative Pain Treatment
|
||
Completed |
NCT02653703 -
L-menthol as a Topical Counter-irritant to TRPA1-induced Neurogenic Inflammation and Pain
|
N/A | |
Completed |
NCT02253966 -
Preoperative Intraarticular Injection of Methylprednisolone in Patients Scheduled for Total Knee-arthroplasty
|
Phase 2 | |
Completed |
NCT01702389 -
Opioid-induced Hyperalgesia After Remifentanil Infusion
|
Phase 4 | |
Terminated |
NCT01615510 -
Evaluation of the Antihyperalgesic Effect of Tapentadol in Two Human Experimental Models
|
Phase 1 | |
Completed |
NCT00218374 -
Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced Hyperalgesia
|
N/A | |
Completed |
NCT00387413 -
A Study Of GSK189254 And Duloxetine In The Electrical Hyperalgesia Model Of Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04197154 -
Pain-related Fear as a Facilitator of Nocebo Hyperalgesia
|
N/A | |
Completed |
NCT02976337 -
Effect of High-dose Naloxone Following Third Molar Extraction
|
Phase 2 | |
Completed |
NCT03354624 -
Cortical Neuroplasticity by Muscle Pain of Pain-induced Plasticity
|
N/A | |
Completed |
NCT02596360 -
Dextromethorphan Effect on Central Sensitization to Pain in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT01480765 -
Preventing Pain After Heart Surgery
|
Phase 4 | |
Recruiting |
NCT01015482 -
The Effect of High-dose Remifentanil on Established Sunburn-induced Hyperalgesia in Human Volunteers (HighDose RemiSun)
|
Phase 4 | |
Completed |
NCT01025245 -
Effect of Intraoperative Magnesium on Remifentanil-induced Postoperative Hyperalgesia After Thyroidectomy
|
Phase 4 |